It is interesting that CTCL-enriched DCs showed higher expression of Galectin LGALS9 and the gene encoding the tumor necrosis factor (TNF) ligand TNFSF12, molecules known to negatively regulate TH1 cell immunity47 and mediate tumor immune responses48 (Fig. 6c). Here, TNFSF12 is linked to neoplasm.